Zhu Hai-xia, Cai Fang-cheng, Zhang Xiao-ping
Department of Neurology, Children's Hospital, Chongqing University of Medical Sciences, Chongqing 400014, China.
Zhonghua Er Ke Za Zhi. 2007 Feb;45(2):121-5.
To explore the possibility of brain damage induced by several anti-epileptic drugs (AEDs) at therapeutic level to immature brain of rat.
Totally 160 healthy Spraque-Dawley (SD) rats selected for the study were divided into infant and adult groups. Each age group was treated with phenobarbital (PB), clonazepam (CZP), valproic acid (VPA), topiramate (TPM) or normal saline respectively for 2 or 5 weeks with 8 rats in each group. The steady-state plasma concentrations of AEDs at the experimental dosage were coincided with the range of clinical therapeutic concentrations. Drug levels in plasma were determined by fluorescence polarization. Body and brain weights were measured when the rats were sacrificed. Histological studies on the tissues of frontal lobes and hippocampus were performed by Nissl staining. And ultrastructural changes of brain were observed by the transmission electron microscopy. Plasma neuron-specific enolase (NSE) was determined by ELISA. Expression of apoptosis-related proteins Bcl-2 and Bax in neurons was detected by immunohistochemistry. Neuronal apoptosis was detected by terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL).
(1) There were no significant differences in brain weight among all adults groups. While remarkable reduction of brain weight was observed in immature rats exposed to CZP or PB (P < 0.01) for long term. (2) Significant neurodegeneration, neuronal necrosis and decrease in the number of neurons can be observed in the immature rats exposed to CZP or PB for long period. (3) For immature rats, concentration of plasma NSE was increased even after short-term treatment with PB [(8.84 +/- 2.10) nmol/L] compared with control group [(6.27 +/- 1.27) nmol/L] (P < 0.01). And it was increased in immature rats exposed to CZP [(8.15 +/- 1.67) nmol/L] or PB [(8.07 +/- 1.27) nmol/L] for long term compared with controls [(6.02 +/- 1.20) nmol/L] (P < 0.01). But there were no significant differences between AEDs-treated adult rats and control rats. (4) The expression of Bcl-2 and Bax protein in mature brain did not change at therapeutic level. In contrast, expression of Bax protein in the frontal lobe was increased significantly in immature rats receiving CZP and PB for long period compared with control. (5) The number of TUNEL positive cells in immature rats exposed to CZP or PB for long term was obviously increased.
PB and CZP may result in remarkable histological abnormalities, neuronal apoptosis and necrosis in immature brain. The brain damage induced by PB was more serious and persistent than that induced by CZP.
探讨几种抗癫痫药物(AEDs)在治疗剂量下对幼鼠未成熟脑造成损伤的可能性。
选取160只健康的Spraque-Dawley(SD)大鼠用于本研究,分为幼年组和成年组。每个年龄组分别用苯巴比妥(PB)、氯硝西泮(CZP)、丙戊酸(VPA)、托吡酯(TPM)或生理盐水处理2周或5周,每组8只大鼠。实验剂量下AEDs的稳态血浆浓度与临床治疗浓度范围相符。采用荧光偏振法测定血浆药物浓度。处死大鼠时测量体重和脑重。通过尼氏染色对额叶和海马组织进行组织学研究。采用透射电子显微镜观察脑的超微结构变化。采用酶联免疫吸附测定法(ELISA)测定血浆神经元特异性烯醇化酶(NSE)。通过免疫组织化学检测神经元中凋亡相关蛋白Bcl-2和Bax的表达。采用末端脱氧核苷酸转移酶生物素-dUTP缺口末端标记法(TUNEL)检测神经元凋亡。
(1)所有成年组的脑重无显著差异。而长期暴露于CZP或PB的幼鼠脑重显著降低(P<0.01)。(2)长期暴露于CZP或PB的幼鼠可观察到明显的神经退行性变、神经元坏死和神经元数量减少。(3)对于幼鼠,与对照组[(6.27±1.27)nmol/L]相比,即使短期给予PB[(8.84±2.10)nmol/L]后血浆NSE浓度也升高(P<0.01)。长期暴露于CZP[(8.15±1.67)nmol/L]或PB[(8.07±1.27)nmol/L]的幼鼠与对照组[(6.02±1.20)nmol/L]相比血浆NSE浓度升高(P<0.01)。但AEDs治疗的成年大鼠与对照大鼠之间无显著差异。(4)在治疗剂量下,成熟脑中Bcl-2和Bax蛋白的表达无变化。相反,长期接受CZP和PB的幼鼠额叶中Bax蛋白的表达与对照组相比显著增加。(5)长期暴露于CZP或PB的幼鼠中TUNEL阳性细胞数量明显增加。
PB和CZP可能导致幼鼠脑出现明显的组织学异常、神经元凋亡和坏死。PB所致的脑损伤比CZP更严重且更持久。